Researchers At Israel’s Rambam Hospital:  Cannabis May Help Severely Ill COVID-19 Patients

ISRAEL: Rambam Health Care Campus is leading cannabis research that could be helpful in the treatment of severely ill COVID-19 patients. Clinical trials have been scheduled. Researchers in the Center for Cannabis Research at Rambam Health Care Campus, led by the center’s Director Dr. Igal Louria-Hayon, hope to study the effects of cannabis use on Read the full article…

CannaTech Tel Aviv & PsyTech Summit Postponed

New Dates PsyTech Summit: June 14-15, 2020 CannaTech Tel Aviv: June 15-16, 2020 ISRAEL: In light of developing circumstances with the COVID-19 coronavirus and based on recommendations from the Israeli Ministry of Health, the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), CannaTech Tel Aviv and PsyTech Summit are postponed.  PsyTech Summit will take place June Read the full article…

Tilray Exports First-Ever Shipment Of Medical Cannabis Allowed Into Israel

CANADA: Tilray, a global pioneer in cannabis research, cultivation, production and distribution, today announced it has entered into an agreement with Canndoc Ltd., a wholly-owned subsidiary of InterCure Ltd., through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda., to export a wholesale shipment of up to 2.5 tonnes of medical cannabis from Portugal to Israel. The shipment, Read the full article…

iCAN: Israel-Cannabis And Headquarters Announce Strategic Partnership

ISRAEL: iCAN: Israel-Cannabis, Israel’s leading cannabis incubator and Headquarters (HQ), a Los Angeles based product accelerator and cannabis license holder with distribution and manufacturing facilities, have formed a strategic partnership to identify the most innovative Israeli cannabis companies and products, and provide them with access to the California market, via distribution, sales and marketing support. Saul Kaye, Read the full article…

iCAN: Israel-Cannabis CEO Saul Kaye Comments on New Israeli Cannabis Initiatives

ISRAEL: Kupat Holim Meuhedet, Israel’s third largest health maintenance organization (HMO), announced yesterday that it was opening an internal cannabis unit using a digitalized system that will allow for significantly faster medical cannabis approval for patients in need. In the framework of the new independent unit, the family doctor will transfer the request of the Meuhedet Read the full article…

China’s Thalys And iCAN: Israel-Cannabis Sign MOU For Co-Investment In Cannabis & Hemp Related Startups

ISRAEL: Thalys Medical Technology, a leading Chinese healthcare conglomerate listed on the Shanghai Stock Exchange (603716.SS), signed a Memorandum of Understanding with iCAN Israel-Cannabis, Israel’s leading medical cannabis incubator. Thalys and iCAN will come together to create a unique partnership to advance the development of early stage incubated companies that focus on the creation of medical technology, Read the full article…

iCAN Secures Financing Through A Convertible Loan Of CAD $4 million (US $3 million)

ISRAEL: iCAN: Israel-Cannabis has announced that it has issued a secured convertible loan in the amount of CAD $4,000,000 to a group of investors led by Plaza Capital. The principal amount of each Convertible Security, plus accrued interest shall be convertible, for no additional consideration, into common shares of the Company at the option of the holders at Read the full article…

CannaTech Tel Aviv 2019 Returns April 1-3, 2019

ISRAEL: Israel’s CannaTech conference returns to Tel Aviv, the global capital of medical cannabis —  a place where innovative Israeli researchers and scientists, high tech experts and “Start-Up Nation” entrepreneurs have fused their knowledge and skills with other world leaders in the industry to develop cutting edge expertise. The main events will take place at Trask, in the Read the full article…

Global Science & Business Leaders Converge For Panama’s First Medical Cannabis Conference February 12-13, 2019

ISRAEL: The world’s leading cannabis researchers and scientists, ag-tech, pharma experts, regulators, investors, and entrepreneurs will share their knowledge about the burgeoning medical cannabis industry at CannaTech Panama, Panama’s first ever international Summit for Accelerating Medical Cannabis Innovation. The main event will take place February 12-13, 2019 at the Central Hotel in Casco Viejo. According to Saul Read the full article…

New Study: Children With Autism See Improvement After Treatment With Tikun Olam High-CBD, Low-THC Medical Cannabis

NEW YORK: Children with Autism Spectrum Disorder (ASD) see a “significant” improvement in symptoms and less reliance on other medications after treatment with Tikun Olam’s Avidekel™ medical cannabis, as confirmed by a new study published in Scientific Reports. The two-year study, “Real Life Experience Of Medical Cannabis Treatment In Autism: Analysis Of Safety And Efficacy,” followed 188 Read the full article…